A Closer Look at IDEXX Laboratories's Options Market Dynamics

Deep-pocketed investors have adopted a bullish approach towards IDEXX Laboratories IDXX, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in IDXX usually suggests something big is about to happen.

We gleaned this information from our observations today when Benzinga's options scanner highlighted 14 extraordinary options activities for IDEXX Laboratories. This level of activity is out of the ordinary.

The general mood among these heavyweight investors is divided, with 71% leaning bullish and 28% bearish. Among these notable options, 3 are puts, totaling $195,980, and 11 are calls, amounting to $548,686.

Expected Price Movements

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $290.0 to $580.0 for IDEXX Laboratories over the last 3 months.

Analyzing Volume & Open Interest

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.

This data can help you track the liquidity and interest for IDEXX Laboratories's options for a given strike price.

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of IDEXX Laboratories's whale activity within a strike price range from $290.0 to $580.0 in the last 30 days.

IDEXX Laboratories Option Activity Analysis: Last 30 Days

Noteworthy Options Activity:

About IDEXX Laboratories

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.

Following our analysis of the options activities associated with IDEXX Laboratories, we pivot to a closer look at the company's own performance.

Present Market Standing of IDEXX Laboratories

• With a volume of 447,358, the price of IDXX is up 0.54% at $530.0.
• RSI indicators hint that the underlying stock may be approaching overbought.
• Next earnings are expected to be released in 0 days.

Professional Analyst Ratings for IDEXX Laboratories

A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $587.5.

• An analyst from Piper Sandler has revised its rating downward to Neutral, adjusting the price target to $525.
• Maintaining their stance, an analyst from Goldman Sachs continues to hold a Buy rating for IDEXX Laboratories, targeting a price of $650.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for IDEXX Laboratories with Benzinga Pro for real-time alerts.